medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2026, Number 2

<< Back Next >>

Acta Med 2026; 24 (2)

Prevalence of malignant bone tumors in ''General Ignacio Zaragoza'' ISSSTE Regional Hospital

Braña RK, Mora RFG, Alanis NML, Domínguez GRC, Rosas MR, Millán DG, Pérez JEI

Language: Spanish
References: 18
Page: 102-107
PDF size: 253.10 Kb.


ABSTRACT

Introduction: malignant bone tumors constitute a heterogeneous group of neoplasms, representing between 15 and 20% of malignant bone lesions. Objective: to know the prevalence of malignant bone tumors in ISSSTE Regional Hospital "General Ignacio Zaragoza". Material and methods: a sample of 199 patients was obtained between 2018 and 2023, and the data were collected for subsequent statistical analysis. Results: 102 women (51.3%) and 97 men (48.7%), with a higher prevalence in middle-aged adults (39.7%), followed by children and older adults (22.6% each), and young adults (15.1%). Osteosarcomas and Ewing sarcomas are more frequent in young patients. Chondrosarcomas and metastases are more common in older adults. Conclusion: the insights derived from this study facilitate progress toward a more efficient and targeted management of malignant bone tumors, along with their contribution to knowledge about epidemiology of malignant bone tumors and their potential impact on improving the diagnosis and treatment of these conditions.


REFERENCES

  1. Schajowicz F. Histological typing of bone tumors. World Health Organization International Histological Classification of Tumors. Berlin: Springer-Verlag; 1993.

  2. Boyer MI, editor. Sección 4. Patología oncológica y sistemática. En: AAOS Comprehensive Orthopaedic Review 2. edición en español. American Academy of Orthopaedic Surgeons; 2014.

  3. Epidemiology of bone tumors in Mexico City: retrospective clinicopathologic study of 566 patients at a referral institution. Ann Diagn Pathol. 2009; 13 (1): 16-21. doi: 10.1016/j.anndiagpath.2008.07.005.

  4. Lam SW, van IJzendoorn DGP, Cleton-Jansen AM, Szuhai K, Bovée JVMG. Molecular pathology of bone tumors. J Mol Diagn. 2019; 21 (2): 171-182. doi: 10.1016/j.jmoldx.2018.11.002.

  5. Xu Y, Shi F, Zhang Y, Yin M, Han X, Feng J et al. Twenty-year outcome of prevalence, incidence, mortality and survival rate in patients with malignant bone tumors. Int J Cancer. 2024; 154 (2): 226-240. doi: 10.1002/ijc.34694.

  6. Schulte M, Hartmann W. Knochentumoren des Kindes- und Jugendalters [Bone tumors in children and adolescents]. Pathologie (Heidelb). 2023; 44 (6): 348-356. doi: 10.1007/s00292-023-01235-z.

  7. Survival outcomes in pediatric patients with metastatic Ewing sarcoma who achieve a rapid complete response of pulmonary metastases. Pediatr Blood Cancer. 2024; 71 (7): e31026. doi: 10.1002/pbc.31026.

  8. Engel H, Herget GW, Füllgraf H, Sutter R, Benndorf M, Bamberg F et al. Chondrogenic bone tumors: the importance of imaging characteristics. Rofo. 2021; 193 (3): 262-274.

  9. Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev. 2001; 27 (3): 165-176.

  10. Xi Y, Qiao L, Na B, Liu H, Zhang S, Zheng R et al. Primary malignant bone tumors incidence, mortality, and trends in China from 2000 to 2015. Chin Med J (Engl). 2023; 136 (17): 2037-2043. doi: 10.1097/CM9.0000000000002547.

  11. Sadykova LR, Ntekim AI, Muyangwa-Semenova M, Rutland CS, Jeyapalan JN, Blatt N et al. Epidemiology and risk factors of osteosarcoma. Cancer Invest. 2020; 38 (5): 259-269. doi: 10.1080/07357907.2020.1768401.

  12. Strauss SJ, Frezza AM, Abecassis N, Bajpai J, Bauer S, Biagini R et al. Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2021; 32 (12): 1520-1536. doi: 10.1016/j.annonc.2021.08.1995.

  13. Ozturk R, Arikan SM, Bulut EK, Kekec AF, Celebi F, Güngor BS. Distribution and evaluation of bone and soft tissue tumors operated in a tertiary care center. Acta Orthop Traumatol Turc. 2019; 53 (3): 189-194. doi: 10.1016/j.aott.2019.03.008.

  14. Yang C, Tian Y, Zhao F, Chen Z, Su P, Li Y et al. Bone microenvironment and osteosarcoma metastasis. Int J Mol Sci. 2020; 21 (19): 6985. doi: 10.3390/ijms21196985.

  15. Jobke B, Werner M. Osteogenic tumors of bone. Radiologe. 2016; 56 (6): 489-506. doi: 10.1007/s00117-016-0119-5.

  16. Govallo VI, Grigor'eva MP, Kosmiadi GA, Zatsepin ST. [Comparative analysis of immunoreactive indices in malignant and benign bone tumors]. Vopr Onkol. 1984; 30 (10): 19-25.

  17. Khan M, Patel R, Youssef M, Banerjee R, Pardiwala A, Belen C. A systemic review of primary malignant long bone tumors in children and adolescents. Acta Chir Orthop Traumatol Cech. 2024; 91 (2): 77-87. doi: 10.55095/ACHOT2024/010.

  18. Cecchini MG, Wetterwald A, Pluijm G van der, Thalmann GN. Molecular and biological mechanisms of bone metastasis. EAU Update Ser. 2005; 3 (4): 214-226.




2020     |     www.medigraphic.com